Search - tctmd.com

Displaying 281 - 300 of 1102

Sort: Relevancy | Date

New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders

News Daily News

New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders

Yael L. Maxwell

March 06, 2020

Validated ARC-HBR Criteria Highlight ‘Eye-opening’ Proportion of PCI Patients at Risk

News Daily News

Validated ARC-HBR Criteria Highlight ‘Eye-opening’ Proportion of PCI Patients at Risk

Yael L. Maxwell

March 03, 2020

Antiplatelets Add Risk in Newly Diagnosed A-fib Patients: GARFIELD-AF

News Daily News

Antiplatelets Add Risk in Newly Diagnosed A-fib Patients: GARFIELD-AF

March 02, 2020

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

February 28, 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

News Conference News CRT 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Michael O'Riordan

February 26, 2020

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

News Conference News CRT 2020

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

Michael O'Riordan

February 25, 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

News Conference News CRT 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

February 25, 2020

Cirrhosis Tied to Poor Outcomes in the Months After PCI

News Daily News

Cirrhosis Tied to Poor Outcomes in the Months After PCI

February 12, 2020

ACS After TAVR a Unique Condition With Poor Prognosis

News Daily News

ACS After TAVR a Unique Condition With Poor Prognosis

February 05, 2020

SYNTAX Score Predicts Long-term Benefits of Left Main PCI and CABG: MAIN-COMPARE

News Daily News

SYNTAX Score Predicts Long-term Benefits of Left Main PCI and CABG: MAIN-COMPARE

Michael O'Riordan

February 03, 2020

Dual Antiplatelet therapy: How Long to Continue after PC

Presentation BIT 2020

Dual Antiplatelet therapy: How Long to Continue after PC

Presenter: Baren Chakraborty

February 02, 2020

Embolization Coils May Be an Option for Leaks After LAA Occlusion

News Daily News

Embolization Coils May Be an Option for Leaks After LAA Occlusion

January 15, 2020

News Daily News

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

January 15, 2020

The Cancer Patient Needing PCI Poses Conundrums for Care

News Features

The Cancer Patient Needing PCI Poses Conundrums for Care

January 14, 2020

Conversations in Cardiology: In the ISCHEMIA Era, What Role for FFR?

News Opinion Conversations in Cardiology

Conversations in Cardiology: In the ISCHEMIA Era, What Role for FFR?

January 02, 2020

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

December 10, 2019

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

ACC/AHA Guideline Writers’ Disclosures vs Open Payments Don’t Add Up

News Daily News

ACC/AHA Guideline Writers’ Disclosures vs Open Payments Don’t Add Up

December 05, 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

News Conference News AHA 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

November 17, 2019

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

News Conference News AHA 2019

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

Yael L. Maxwell

November 17, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.